BC-011

N/A

Report date: 2024/08/23 14:06:47

Base Information

Drug NameBC-011
Drug Alias NameBC-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B modulators
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesDragonboat Biopharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesDragonboat Biopharmaceutical
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A